Browse by Audience
Skip to content
Papers of the Week
Systemic administration of serotonin exacerbates abdominal pain and colitis via interaction with the endocannabinoid system.
Abstract
Molecular basis of abdominal pain in IBD is not fully characterized. Serotonin (5-HT) increases visceral pain severity and contributes to exacerbation of inflammation. Moreover, it is well established that decreased anandamide (AEA) signaling in the gut increases visceral pain severity. The aim of this study was to investigate the interplay between 5-HT and endocannabinoid signaling in colitis.